Phoenix Biotech Acquisition Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 0.667736 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9178 USD | -2.37% | -13.42% | -91.66% |
1st Jan change | Capi. | |
---|---|---|
-91.66% | 13.51M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.66% | 22.1B | |
-9.14% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022